Estrogen-Androgen Hormone Replacement Therapy

  • Morrie M. Gelfand
Part of the Medical Science Symposia Series book series (MSSS, volume 13)


The term “menopause” is a key word for health professionals caring for the aging woman. It makes no difference whether you call it “change of life” or “climacteric” or “the change” or in fact “normal aging.” It is a fact of life that there are significant changes in hormone production whether the ovaries are removed surgically or whether they atrophy normally. There are 3 major hormones produced by the ovary, namely, estrogen, progestin, and androgen. There is therefore a responsibility for the health professional to come to grips with the care of the aging woman. The hormone deficiency should be taken into account. During the next 10 years, there will be a dramatic increase in the number of women who are entering the menopause and we as obstetricians and gynecologists should be the prime health providers for the care of this population.


Hormone Replacement Therapy Obstet Gynecol Testosterone Replacement Therapy Methyl Testosterone Surgical Menopause 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Longcope C. Adrenal and androgen secretions of normal women. Clin Endocrinol Metab 1986;15:213–28.PubMedCrossRefGoogle Scholar
  2. 2.
    Judd HL, Judd GE, Lucas WE, et al. Endocrine function of the postmenopausal ovary-concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 1974;39:1020–24.PubMedCrossRefGoogle Scholar
  3. 3.
    Greenblatt RB, Williams E, Barfield, et al. Evaluation of an estrogen-androgen combination and a placebo in the treatment of the menopause. J Clin Endocrinol Metab 1950;10;15, 47–52.Google Scholar
  4. 4.
    Grody MH, Lampie EH. Estrogen-androgen substitution therapy in the aged female. Obstet Gynecol 1953;2:36–41.PubMedGoogle Scholar
  5. 5.
    Studd JWW, Collins WP. Estradiol and testosterone implants in the treatment of psychosexual problems in the postmenopausal woman. Br J Gynecol 1977;84:314–15.Google Scholar
  6. 6.
    Brincat M, Studd JWW, O’Dowd T, et al. Subcutaneous implants for control of climacteric symptoms. Lancet 1984;1:16–18.PubMedCrossRefGoogle Scholar
  7. 7.
    Sherwin BB, Gelfand MM. Effects of parenteral administration of estrogen and androgen on plasma hormone levels and hot flashes in the surgical menopause. Am J Obstet Gynecol 1984;148:552–57.PubMedGoogle Scholar
  8. 8.
    Sherwin BB, Gelfand MM. Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol 1985;151:153–60.PubMedGoogle Scholar
  9. 9.
    Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: A cross-over study of sex steroid administration in the surgical menopause. Psychosoin Med 1985;47:339–51.Google Scholar
  10. 10.
    Sherwin BB, Gelfand MM. Sex steroids and effect in the surgical menopause: A double-blind, cross-over study. Psychoneuroendocrinology 1985;10;325–35.PubMedCrossRefGoogle Scholar
  11. 11.
    Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987;49:397–409.PubMedGoogle Scholar
  12. 12.
    Gelfand MM. Estrogen-androgen honnone replacement. In: Swartz DP, editor. Hormone replacement therapy. London: Williams & Wilkins, 1992;221–34.Google Scholar
  13. 13.
    Gelfand MM, Ferenczy A, Bergeron C. Endometrial response to estrogen-androgen Stimulation. In: Hammond CB, Haseltine FP, editors. Menopause: Evaluation, treatment and health concerns. New York: Alan R. Liss, 1989:29–40.Google Scholar
  14. 14.
    Ettinger B, Genant HK, Steiger P, et al. Low-dosage micronized 17-β estradiol prevents bone loss in postmenopausal women. Am J Obstet Gynecol 1992;166:479–88.PubMedGoogle Scholar
  15. 15.
    Notelovitz M. Osteoporosis: Screening, prevention, and management. Fertil Steril 1993;59:707–25.PubMedGoogle Scholar
  16. 16.
    Longcope C, Baker RS, et al. Androgen and estrogen dynamics in women with vertebral crush fractures. Maturitas 1984;6:309.PubMedCrossRefGoogle Scholar
  17. 17.
    Hassager C, Reis BJ, et al. Nandrolone decanoate treatment of postmenopausal osteoporosis for two years and effects of withdrawal. Maturitas 1989;11:305–17.PubMedCrossRefGoogle Scholar
  18. 18.
    Passeri M, Pedrazzoni M, Pioli G, et al. Effects of nandrolone decanoate on bone mass in established osteoporosis. Maturitas 1993;17:211–19.PubMedCrossRefGoogle Scholar
  19. 19.
    Watts NB, Notelovitz M, Timmons MC, et al. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgically menopausal women. Obstet Gynecol 1995;85:529–37.PubMedCrossRefGoogle Scholar
  20. 20.
    Sherwin BB, Gelfand MM. A prospective one-year study of estrogen and progestin in postmenopausal women: Effects on clinical symptoms and lipoprotein lipids. Obstet Gynecol 1989;73:759–66.PubMedGoogle Scholar
  21. 21.
    Friedl KE, Hannan Jr, CJ, Jones RE, et al. High density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered. Metabolism 1990;39:69–74.PubMedCrossRefGoogle Scholar
  22. 22.
    Sherwin BB, Gelfand MM, Schucher R, et al. Postmenopausal estrogen and androgen replacement and lipoprotein-lipid concentrations. Am J Obstet Gynecol 1987;4;414–19.Google Scholar
  23. 23.
    Lovell CW. Breast cancer incidence with parenteral estradiol and testosterone replacement therapy. Menopause. Abst North Am Menopause Soc 1994;1(3):150.Google Scholar
  24. 24.
    Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG. Estrogen replacement therapy in older women. Arch Neurol 1994;51:896.PubMedGoogle Scholar
  25. 25.
    Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer’s disease in women. Am J Epidemiol 1994;140(3):256.PubMedGoogle Scholar
  26. 26.
    Davis SR, McCloud P, Strauss BJG, et al. Testosterone enhances estradiol’s effects on postmenopausal bone density and sexuality. Maturitas 1995;21:227–36.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers and Fondazione Giovanni Lorenzini 1999

Authors and Affiliations

  • Morrie M. Gelfand

There are no affiliations available

Personalised recommendations